Article
Product release is rate-limiting for catalytic processing by the Dengue virus protease.
Scientific reports - 29 Nov 2016
Shannon A E, Pedroso M M, Chappell K J, Watterson D, Liebscher S, Kok W M, Fairlie D P, Schenk G, Young P R
Abstract excerpt
Dengue Virus (DENV) is the most prevalent global arbovirus, yet despite an increasing burden to health care there are currently no therapeutics available to treat infection. A potential target for antiviral drugs is the two-component viral protease NS2B-NS3pro, which is essential for viral replication. Interactions between the two components have been investigated here by probing the effect on the rate of enzyme...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
